Total Payments
$11,417
2024 Payments
$2,235
Companies
46
Transactions
435
Medicare Patients
8,394
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$11,401 (99.9%)
Education$15.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,401 | 433 | 99.9% |
| Education | $15.93 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,923 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,363 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,291 | 42 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,222 | 31 | $0 (2024) |
| Lilly USA, LLC | $894.37 | 48 | $0 (2024) |
| Amgen Inc. | $557.54 | 32 | $0 (2023) |
| Abbott Laboratories | $493.13 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $436.62 | 10 | $0 (2024) |
| PFIZER INC. | $309.69 | 11 | $0 (2024) |
| Medtronic, Inc. | $294.95 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,235 | 86 | Bayer Healthcare Pharmaceuticals Inc. ($465.63) |
| 2023 | $1,952 | 86 | Bayer Healthcare Pharmaceuticals Inc. ($359.98) |
| 2022 | $2,762 | 113 | Novo Nordisk Inc ($639.13) |
| 2021 | $1,510 | 67 | GlaxoSmithKline, LLC. ($402.11) |
| 2020 | $1,116 | 47 | GlaxoSmithKline, LLC. ($582.37) |
| 2019 | $980.67 | 22 | Novo Nordisk Inc ($339.57) |
| 2018 | $663.45 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($147.56) |
| 2017 | $198.13 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($120.21) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Obesity | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: DIABETES | ||||||
| 11/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Hyperkalemia | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $45.48 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: VACCINE | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: Cardio-renal | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: PAIN | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $87.30 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,303 | 6,050 | $2.1M | $357,023 |
| 2022 | 20 | 2,125 | 14,872 | $2.5M | $484,606 |
| 2021 | 19 | 1,805 | 5,341 | $1.9M | $350,555 |
| 2020 | 18 | 2,161 | 4,074 | $1.8M | $274,764 |
Total Patients
8,394
Total Services
30,337
Medicare Billing
$1.5M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 874 | 2,338 | $1.3M | $219,783 | 17.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 26 | 1,802 | $90,000 | $33,231 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 281 | 281 | $280,157 | $32,441 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 340 | 450 | $168,750 | $30,703 | 18.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 39 | 137 | $61,924 | $10,967 | 17.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $52,644 | $10,827 | 20.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 409 | 618 | $12,712 | $5,191 | 40.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $16,692 | $2,671 | 16.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 38 | 61 | $21,899 | $2,621 | 12.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 21 | 21 | $18,333 | $2,554 | 13.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 45 | $14,085 | $1,764 | 12.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $6,720 | $973.19 | 14.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 78 | 79 | $11,455 | $921.12 | 8.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 12 | $2,016 | $909.72 | 45.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 66 | $18,150 | $732.06 | 4.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $2,376 | $694.32 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $360.00 | $40.92 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 792 | 3,121 | $1.7M | $305,398 | 17.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 11 | 7,770 | $157,920 | $59,047 | 37.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 32 | 2,221 | $111,050 | $37,432 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 277 | 277 | $276,169 | $32,245 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 139 | $52,125 | $9,853 | 18.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 113 | 175 | $42,700 | $8,684 | 20.3% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 42 | 80 | $47,520 | $6,694 | 14.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $25,680 | $5,298 | 20.6% |
About Dr. David Selzer, M.D
Dr. David Selzer, M.D is a Internal Medicine healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1194069377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Selzer, M.D has received a total of $11,417 in payments from pharmaceutical and medical device companies, with $2,235 received in 2024. These payments were reported across 435 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($11,401).
As a Medicare-enrolled provider, Selzer has provided services to 8,394 Medicare beneficiaries, totaling 30,337 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location West Palm Beach, FL
- Active Since 11/12/2012
- Last Updated 03/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194069377
Products in Payments
- Kerendia (Drug) $1,222
- JARDIANCE (Drug) $869.25
- Ozempic (Drug) $820.91
- TRELEGY ELLIPTA (Drug) $694.22
- MOUNJARO (Drug) $538.59
- NUCALA (Biological) $417.73
- Rybelsus (Drug) $410.46
- Wegovy (Drug) $355.34
- PRADAXA (Drug) $315.83
- Mitra Clip system (Device) $294.88
- Evera (Device) $265.55
- MICRA (Device) $218.49
- EVENITY (Biological) $203.64
- Otezla (Drug) $190.82
- NURTEC ODT (Drug) $179.26
- ELIQUIS (Drug) $171.14
- GEMTESA (Drug) $154.02
- LEQVIO (Drug) $152.29
- ZEPBOUND (Drug) $143.35
- LifeVest (Device) $132.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Palm Beach
Dr. David Liporace, D.o, D.O
Internal Medicine — Payments: $203,201
Internal Medicine $203,201
Florencia Ziemke, M.d, M.D
Internal Medicine — Payments: $134,388
Internal Medicine $134,388
Sonja Olsen, M.d, M.D
Internal Medicine — Payments: $74,158
Internal Medicine $74,158
Mira Baron, Md, Cpi, MD, CPI
Internal Medicine — Payments: $68,606
Internal Medicine $68,606
Dr. Gabriel Gemayel, Md, MD
Internal Medicine — Payments: $10,220
Internal Medicine $10,220
Dr. Mark Rattinger, Md, MD
Internal Medicine — Payments: $9,711
Internal Medicine $9,711